Bridgeway Capital Management, LLC Clearside Biomedical, Inc. Transaction History

Bridgeway Capital Management, LLC

$3.75 Billion
Q1 2025

A detailed history of Bridgeway Capital Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 255,000 shares of CLSD stock, worth $124,950. This represents 0.01% of its overall portfolio holdings.

Number of Shares

255,000

Previous 255,000 -0.0%

Holding current value

$124,950

Previous $255,000 8.24%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.93 - $1.35 $116,250 - $168,750	125,000 Added 96.15%	255,000 $323,000
Q2 2024 Aug 14, 2024	SELL	$1.08 - $1.58 $216 - $316	-200 Reduced 0.15%	130,000 $169,000
Q1 2024 May 15, 2024	SELL	$1.2 - $2.02 $54,480 - $91,708	-45,400 Reduced 25.85%	130,200 $199,000
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.27 $85,280 - $132,080	-104,000 Reduced 37.2%	175,600 $152,000
Q2 2023 Aug 14, 2023	SELL	$0.97 - $1.48 $11,640 - $17,760	-12,000 Reduced 4.12%	279,600 $313,000
Q1 2023 May 15, 2023	SELL	$0.93 - $1.66 $23,250 - $41,500	-25,000 Reduced 7.9%	291,600 $303,000
Q2 2021 Aug 16, 2021	BUY	$2.32 - $5.38 $92,800 - $215,200	40,000 Added 14.46%	316,600 $1.54 Million
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $207,424 - $393,550	92,600 Added 50.33%	276,600 $683,000
Q2 2020 Aug 14, 2020	BUY	$1.55 - $2.41 $145,700 - $226,540	94,000 Added 104.44%	184,000 $346,000
Q1 2019 May 15, 2019	SELL	$1.1 - $1.74 $54,120 - $85,608	-49,200 Reduced 35.34%	90,000 $124,000
Q3 2018 Nov 13, 2018	BUY	$6.03 - $11.24 $391,950 - $730,600	65,000 Added 87.6%	139,200 $856,000
Q2 2018 Aug 14, 2018	SELL	$8.91 - $14.54 $337,689 - $551,066	-37,900 Reduced 33.81%	74,200 $793,000
Q3 2017 Nov 14, 2017	BUY	$6.73 - $8.74 $754,433 - $979,754	112,100	112,100 $980,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

11M

Call Options Held

5.9K

Put Options Held

86.6K

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $29.5M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Clearside Biomedical, Inc. Transaction History